
Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients
Keywords: Proteoglycan receptor; Lipoproteins; Nanoplaque formation; Ginkgo biloba; Clinical trial; Ellipsometry